937 results on '"Kelsen David"'
Search Results
52. Supplementary from Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection
53. Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma
54. The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging
55. Abstract C028: The lung pro-thrombotic niche drives cancer-associated thromboembolism and metastasis via extracellular vesicle ITGB2
56. Abstract C016: New treatment modality for pancreatic cancer-Vascular Targeted Photodynamic therapy with WST11 (Padeliporfin) combined with endovascular light delivery
57. Abstract PR012: Perioperative liver biopsy captures features of the liver pre-metastatic niche and predicts metastatic outcome after pancreatic cancer resection
58. A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma
59. Integrated genomic characterization of oesophageal carcinoma
60. S1014 Immune Checkpoint Inhibitors for Colorectal Cancer in Patients With Inflammatory Bowel Disease
61. Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice
62. Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate data
63. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients
64. A phase 1/1B trial of ADI‐PEG 20 plus nab‐paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma
65. Memorial Sloan-Kettering Cancer Center Experience with Intraperitoneal Chemotherapy for Gastric Cancer
66. Abstract 3138: The lung pro-thrombotic niche drives cancer-associated thromboembolism via exosomal ITGB2
67. Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer
68. Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade.
69. PD-L1 expression and overall survival in Asian and western patients with gastric cancer
70. Small Intestine
71. Stomach
72. Esophagus and Esophagogastric Junction
73. Abstract 6421: Molecular profiles and single cell analysis identify immunogenic pancreatic ductal adenocarcinoma (iPDAC)
74. Adjuvant chemotherapy in gastric adenocarcinomas
75. Additional file 1 of Attitudes toward preimplantation genetic testing and quality of life among individuals with hereditary diffuse gastric cancer syndrome
76. Prognostic Significance of Targetable Angiogenic and Growth Factors in Patients Undergoing Resection for Gastric and Gastroesophageal Junction Cancers
77. Advanced gastric cancer – Slow but steady progress
78. Identification of Germline Genetic Mutations in Patients With Pancreatic Cancer
79. A Phase II Study of Flavopiridol (Alvocidib) in Combination with Docetaxel in Refractory, Metastatic Pancreatic Cancer
80. Endoscopic Ultrasound Can Improve the Selection for Laparoscopy in Patients with Localized Gastric Cancer
81. Prognostic significance of T‐cell–inflamed gene expression profile and PD‐L1 expression in patients with esophageal cancer
82. BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking CLU+ CAF expression with HSF1 signaling
83. Pancreas cancer and BRCA : A critical subset of patients with improving therapeutic outcomes
84. A Man with Klinefelter’s Syndrome and New Abdominal Distension: A Discussion of Evaluation and Management
85. A multicenter, phase II study of Bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma
86. A Woman with Remotely Treated Pancreas Cancer and New Abdominal Pain: A Discussion of Evaluation and Management
87. A 67-Year-Old Woman with BRCA 1 Mutation Associated with Pancreatic Adenocarcinoma
88. Gastrointestinal Cancer Educational Case Series: The History and Management of Complex Cases in GI Oncology. A 72 Year-Old Man with Metastatic Gastric Cancer
89. Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer
90. Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
91. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer
92. Abstract LB204: HSF1 promotes inflammation induced tumor development through ECM remodeling
93. Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients
94. Does Graded Histologic Response After Neoadjuvant Chemotherapy Predict Survival for Completely Resected Gastric Cancer?
95. Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids
96. Artificial Intelligence and Early Detection of Pancreatic Cancer:2020 Summative Review
97. Adjuvant therapy for stage II colorectal cancer: Who and with what?
98. Systemic therapy for advanced gastric cancer: a review
99. Small Cell Carcinomas of the Gastrointestinal Tract: Clinicopathological Features and Treatment Approach
100. Conformation-Specific Inhibitory Anti-MMP-7 Monoclonal Antibody Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Chemotherapeutic Cell Kill
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.